Pfizer Bulks Up Its Generics Business
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with the Indian pharma company Aurobindo highlights the giant’s interest in expanding its product mix.
You may also be interested in...
Pfizer Ramps Up Its Biosimilars Business
Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest
Pfizer Ramps Up Its Biosimilars Business
Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest
Pfizer Leaps Into Japanese Generics Foray; Aims For 100 Generic Products By 2011
Pfizer's Established Products Business Unit, a branch in charge of invigorating off-patent drugs and leading generic drug activities, will establish commercial operations in Japan starting Dec. 1